Back to search
FDAFDA · Food and drugs·Recall number D-0078-2022

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

Published November 3, 2021 · Recall initiated: October 18, 2021

Summary

FDA records drug Class III recall D-0078-2022, published November 3, 2021 and initiated October 18, 2021. Recalling firm: MACLEODS PHARMA USA, INC; Status: Terminated; Reported quantity: 135,082 Blister Packs/2,431,476 tablets; Lot: Lot #: BRJ2112A, BRJ2113A, BRJ2114A, BRJ2114B, exp. date 04/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

What to do

Voluntary: Firm initiated · Letter

Get an email if RIZATRIPTAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
RIZATRIPTAN
Manufacturer
MACLEODS PHARMA USA, INC
Distributor
Nationwide within the United States
UPC
0333342088468
Lot
Lot #: BRJ2112A, BRJ2113A, BRJ2114A, BRJ2114B, exp. date 04/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA recalled?

Yes. FDA published recall D-0078-2022 on November 3, 2021. Reported hazard: Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: RIZATRIPTAN. UPC: 0333342088468.